| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-09-21 | NCT07832136 An Open-Label Trial of Veligrotug in Participants With Thyroid Eye Disease Who Previously… | Phase 4 | Not Yet Recruiting |
| Phase 3 | 3 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07832136 | An Open-Label Trial of Veligrotug in Participants With Thyroid Eye Disease Who Previously… | Thyroid Eye Disease | Not Yet Recruiting | 2026-09-21 |
| Phase 3 | ||||
| NCT06625398 | An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic… | Thyroid Eye Disease | Active, Not Recruiting | 2026-08-18 |
| NCT06625411 | An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active… | Thyroid Eye Disease | Active, Not Recruiting | 2026-08-18 |
| NCT06812325 | A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED) | Thyroid Eye Disease (TED) | Active, Not Recruiting | 2026-05-22 |